Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19

BACKGROUND: Thromboembolic disease is common in coronavirus disease-2019 (COVID-19). There is limited evidence on the association of in-hospital anticoagulation (AC) with outcomes and postmortem findings. OBJECTIVES: The purpose of this study was to examine association of AC with in-hospital outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Nadkarni, Girish N., Lala, Anuradha, Bagiella, Emilia, Chang, Helena L., Moreno, Pedro R., Pujadas, Elisabet, Arvind, Varun, Bose, Sonali, Charney, Alexander W., Chen, Martin D., Cordon-Cardo, Carlos, Dunn, Andrew S., Farkouh, Michael E., Glicksberg, Benjamin S., Kia, Arash, Kohli-Seth, Roopa, Levin, Matthew A., Timsina, Prem, Zhao, Shan, Fayad, Zahi A., Fuster, Valentin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier on behalf of the American College of Cardiology Foundation 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449655/
https://www.ncbi.nlm.nih.gov/pubmed/32860872
http://dx.doi.org/10.1016/j.jacc.2020.08.041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449655/
https://www.ncbi.nlm.nih.gov/pubmed/32860872
http://dx.doi.org/10.1016/j.jacc.2020.08.041

Ejemplares similares